Sonnet Biotherapeutics Holdings Stock Market Value
| SONN Stock | USD 2.90 0.02 0.68% |
| Symbol | Sonnet |
Sonnet Biotherapeutics Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sonnet Biotherapeutics. If investors know Sonnet will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sonnet Biotherapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.96) | Revenue Per Share 0.019 | Quarterly Revenue Growth (0.50) | Return On Assets (0.97) | Return On Equity (2.65) |
The market value of Sonnet Biotherapeutics is measured differently than its book value, which is the value of Sonnet that is recorded on the company's balance sheet. Investors also form their own opinion of Sonnet Biotherapeutics' value that differs from its market value or its book value, called intrinsic value, which is Sonnet Biotherapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sonnet Biotherapeutics' market value can be influenced by many factors that don't directly affect Sonnet Biotherapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sonnet Biotherapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Sonnet Biotherapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sonnet Biotherapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Sonnet Biotherapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Sonnet Biotherapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Sonnet Biotherapeutics.
| 11/28/2023 |
| 11/22/2024 |
If you would invest 0.00 in Sonnet Biotherapeutics on November 28, 2023 and sell it all today you would earn a total of 0.00 from holding Sonnet Biotherapeutics Holdings or generate 0.0% return on investment in Sonnet Biotherapeutics over 360 days. Sonnet Biotherapeutics is related to or competes with ZyVersa Therapeutics, Allarity Therapeutics, Immix Biopharma, and Cns Pharmaceuticals. Sonnet BioTherapeutics Holdings, Inc., a clinical stage oncology-focused biotechnology company, develops platform for bi... More
Sonnet Biotherapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Sonnet Biotherapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Sonnet Biotherapeutics Holdings upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.13) | |||
| Maximum Drawdown | 37.58 | |||
| Value At Risk | (9.79) | |||
| Potential Upside | 12.31 |
Sonnet Biotherapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Sonnet Biotherapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Sonnet Biotherapeutics' standard deviation. In reality, there are many statistical measures that can use Sonnet Biotherapeutics historical prices to predict the future Sonnet Biotherapeutics' volatility.| Risk Adjusted Performance | (0.08) | |||
| Jensen Alpha | (0.77) | |||
| Total Risk Alpha | (1.58) | |||
| Treynor Ratio | 2.19 |
Sonnet Biotherapeutics Backtested Returns
Sonnet Biotherapeutics owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.14, which indicates the firm had a -0.14% return per unit of risk over the last 3 months. Sonnet Biotherapeutics Holdings exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Sonnet Biotherapeutics' Variance of 46.61, risk adjusted performance of (0.08), and Coefficient Of Variation of (858.68) to confirm the risk estimate we provide. The entity has a beta of -0.37, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Sonnet Biotherapeutics are expected to decrease at a much lower rate. During the bear market, Sonnet Biotherapeutics is likely to outperform the market. At this point, Sonnet Biotherapeutics has a negative expected return of -0.95%. Please make sure to validate Sonnet Biotherapeutics' treynor ratio, kurtosis, as well as the relationship between the Kurtosis and day typical price , to decide if Sonnet Biotherapeutics performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.35 |
Poor reverse predictability
Sonnet Biotherapeutics Holdings has poor reverse predictability. Overlapping area represents the amount of predictability between Sonnet Biotherapeutics time series from 28th of November 2023 to 26th of May 2024 and 26th of May 2024 to 22nd of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Sonnet Biotherapeutics price movement. The serial correlation of -0.35 indicates that nearly 35.0% of current Sonnet Biotherapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.35 | |
| Spearman Rank Test | -0.48 | |
| Residual Average | 0.0 | |
| Price Variance | 7.86 |
Sonnet Biotherapeutics lagged returns against current returns
Autocorrelation, which is Sonnet Biotherapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Sonnet Biotherapeutics' stock expected returns. We can calculate the autocorrelation of Sonnet Biotherapeutics returns to help us make a trade decision. For example, suppose you find that Sonnet Biotherapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Sonnet Biotherapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Sonnet Biotherapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Sonnet Biotherapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Sonnet Biotherapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Sonnet Biotherapeutics Lagged Returns
When evaluating Sonnet Biotherapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Sonnet Biotherapeutics stock have on its future price. Sonnet Biotherapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Sonnet Biotherapeutics autocorrelation shows the relationship between Sonnet Biotherapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Sonnet Biotherapeutics Holdings.
Regressed Prices |
| Timeline |
When determining whether Sonnet Biotherapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Sonnet Biotherapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Sonnet Biotherapeutics Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Sonnet Biotherapeutics Holdings Stock:
Check out Sonnet Biotherapeutics Correlation, Sonnet Biotherapeutics Volatility and Sonnet Biotherapeutics Alpha and Beta module to complement your research on Sonnet Biotherapeutics. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Sonnet Biotherapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.